CTOs on the Move

Regional Consultants Hematology and Onocology

www.rchopa.com

 
Regional Consultants Hematology and Onocology is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.rchopa.com
  • 1235 San Marco Blvd Ste 3
    Jacksonville, FL USA 32207
  • Phone: 904.493.5100

Executives

Name Title Contact Details

Similar Companies

Tapinator

Tapinator (Ticker: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator’s owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development offices in Pakistan, Denmark and Indonesia.

Citrus Health Care

Citrus Health Care is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mid South Health System

Mid South Health System is a Jonesboro, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amalgamated Life and Health

Amalgamated Life and Health is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.